Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin BCT Pharmaceutical, also known as Jilin Bencaotang Pharmaceutical, is a Chinese pharmaceutical company focused on the development and production of Traditional Chinese Medicine (TCM) and botanical drugs. A subsidiary of Global Pharmatech, Inc., the company manufactures a range of proprietary products including Jin Lian Hua for upper respiratory infections, Gong Yan Kang for gynecological conditions, and Wei Kang Ling for gastrointestinal disorders. Jilin BCT operates manufacturing facilities in Jilin Province and distributes its products both domestically in China and to international markets. The company is recognized for its integration of modern scientific research with traditional herbal medicine. It has successfully navigated the regulatory landscape to bring several botanical drug candidates to the commercial stage in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin BCT Pharmaceutical.